MedTrace Logo

Efficacy Testing of Crassocephalum Rabens Extract Capsules

NCT05309161 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-08-03

No results posted yet for this study

Summary

This study is to investigate the improveing effects of the Crassocephalum rebens extract on skin conditions in normal people.

Conditions

  • Aging

Interventions

DIETARY_SUPPLEMENT

Crassocephalum rabens extract

dosage: a capsule (180 mg)/day; duration: 1 month

Sponsors & Collaborators

  • Chia Nan University of Pharmacy ＆ Science

    collaborator OTHER

  • Greenyn Biotechnology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Chia-Hua Liang · Department of Cosmetic Science, Chia Nan University of Pharmacy ＆ Science

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-14
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05309161 on ClinicalTrials.gov